Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Response to Corticosteroids and Cytotoxic Drugs in a Case of Idiopathic Hypereosinophilic Syndrome with Predominantly Elevated Eosinophils and Multiple Clinical Manifestations

Authors: Zhi-ping Guo, Lin-hua Yang, Jian-fang Chen, Xiu-hua Chen, Yao-fang Zhang

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

In the present case study, a 42-year-old Chinese woman fulfilling the WHO criteria for idiopathic hypereosinophilic syndrome (IHES) who exhibited clinical manifestations of eosinophilic infiltration of multiple tissues including the lungs, heart, central and peripheral nervous system, gastrointestinal tract, spleen, liver and unexplained clinical findings is described. Laboratory investigations revealed the topmost white blood cell and eosinophil that were 150 × 109/L and 136 × 109/L (90.6 %), respectively. To our knowledge, such a large number of eosinophils has rarely been reported, and all reactive causes of hypereosinophilia were excluded. Treatment with cytotoxic chemotherapy, prednisone and dexamethasone was not beneficial. The patient showed a remarkable hematological response when methylprednisolone pulse therapy was initiated when progression of respiratory symptoms occurred, but without clinical remission. The patient subsequently died. We consider that her critical organ damage and poor prognosis were related to the large number of eosinophils and delayed effective anti-eosinophilic therapy after severe organ damage occurred. This case highlights the clinical importance of methylprednisolone pulse therapy which should be initiated without delay once the diagnosis of IHES is made.
Literature
1.
go back to reference Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54:1–27CrossRef Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54:1–27CrossRef
2.
go back to reference Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83:2759–2779PubMed Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83:2759–2779PubMed
3.
go back to reference Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937–951PubMedCrossRef Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937–951PubMedCrossRef
4.
go back to reference Winn RE, Kollef MH, Meyer JI (1994) Pulmonary involvement in the hypereosinophilic syndrome. Chest 105:656–660PubMedCrossRef Winn RE, Kollef MH, Meyer JI (1994) Pulmonary involvement in the hypereosinophilic syndrome. Chest 105:656–660PubMedCrossRef
5.
go back to reference Karnak D, Kayacan O, Beder S, Delibalta M (2003) Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma. CMAJ 168:172–175PubMedPubMedCentral Karnak D, Kayacan O, Beder S, Delibalta M (2003) Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma. CMAJ 168:172–175PubMedPubMedCentral
6.
7.
go back to reference Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH (1982) NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97:78–92PubMedCrossRef Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH (1982) NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97:78–92PubMedCrossRef
8.
go back to reference Moore PM, Harley JB, Fauci AS (1985) Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 102:109–114PubMedCrossRef Moore PM, Harley JB, Fauci AS (1985) Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 102:109–114PubMedCrossRef
9.
go back to reference Spry CJ, Davies J, Tai PC, Olsen EG, Oakley CM, Goodwin JF (1983) Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 52:1–22PubMed Spry CJ, Davies J, Tai PC, Olsen EG, Oakley CM, Goodwin JF (1983) Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 52:1–22PubMed
10.
go back to reference Parrillo JE, Fauci AS, Wolff SM (1978) Therapy of the hypereosinophilic syndrome. Ann Intern Med 89:167–172PubMedCrossRef Parrillo JE, Fauci AS, Wolff SM (1978) Therapy of the hypereosinophilic syndrome. Ann Intern Med 89:167–172PubMedCrossRef
11.
go back to reference Christen R, Morant R, Schneider J, Jenni R, Fehr J (1989) Progressive dilated cardiomyopathy in a patient with longstanding and complete prednisone-induced hematological remission of idiopathic hypereosinophilic syndrome. Klin Wochenschr 67:358–365PubMedCrossRef Christen R, Morant R, Schneider J, Jenni R, Fehr J (1989) Progressive dilated cardiomyopathy in a patient with longstanding and complete prednisone-induced hematological remission of idiopathic hypereosinophilic syndrome. Klin Wochenschr 67:358–365PubMedCrossRef
13.
go back to reference Jabbour E, Verstovsek S, Giles F, Gandhi V, Cortes J, O’Brien S, Plunkett W, Garcia-Manero G, Jackson CE, Kantarjian H, Andreeff M (2005) 2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome. Cancer 104:541–546PubMedCrossRef Jabbour E, Verstovsek S, Giles F, Gandhi V, Cortes J, O’Brien S, Plunkett W, Garcia-Manero G, Jackson CE, Kantarjian H, Andreeff M (2005) 2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome. Cancer 104:541–546PubMedCrossRef
14.
go back to reference Cofrancesco E, Cortellaro M, Pogliani E, Boschetti C, Salvatore M, Polli EE (1984) Response to vincristine treatment in a case of idiopathic hypereosinophilic syndrome with multiple clinical manifestations. Acta Haematol 72:21–25PubMedCrossRef Cofrancesco E, Cortellaro M, Pogliani E, Boschetti C, Salvatore M, Polli EE (1984) Response to vincristine treatment in a case of idiopathic hypereosinophilic syndrome with multiple clinical manifestations. Acta Haematol 72:21–25PubMedCrossRef
15.
go back to reference Sakamoto K, Erdreich-Epstein A, deClerck Y, Coates T (1992) Prolonged clinical response to vincristine treatment in two patients with idiopathic hypereosinophilic syndrome. Am J Pediatr Hematol Oncol 14:348–351PubMedCrossRef Sakamoto K, Erdreich-Epstein A, deClerck Y, Coates T (1992) Prolonged clinical response to vincristine treatment in two patients with idiopathic hypereosinophilic syndrome. Am J Pediatr Hematol Oncol 14:348–351PubMedCrossRef
16.
go back to reference Smit AJ, van Essen LH, de Vries EG (1991) Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. Cancer 67:2826–2827PubMedCrossRef Smit AJ, van Essen LH, de Vries EG (1991) Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. Cancer 67:2826–2827PubMedCrossRef
17.
18.
go back to reference Ito T, Harada K, Takada G (1998) An infant with hypereosinophilic syndrome and heart failure markedly responded to prednisolone: serial changes of left ventricular wall thickening and left ventricular diastolic dysfunction observed by echocardiography. Heart Vessels 13:302–305PubMedCrossRef Ito T, Harada K, Takada G (1998) An infant with hypereosinophilic syndrome and heart failure markedly responded to prednisolone: serial changes of left ventricular wall thickening and left ventricular diastolic dysfunction observed by echocardiography. Heart Vessels 13:302–305PubMedCrossRef
19.
go back to reference Hayashi S, Isobe M, Okubo Y, Suzuki J, Yazaki Y, Sekiguchi M (1999) Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens. Heart Vessels 14:104–108PubMedCrossRef Hayashi S, Isobe M, Okubo Y, Suzuki J, Yazaki Y, Sekiguchi M (1999) Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens. Heart Vessels 14:104–108PubMedCrossRef
20.
go back to reference Kim CH, Vlietstra RE, Edwards WD, Reeder GS, Gleich GJ (1984) Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. Am J Cardiol 53:1472–1473PubMedCrossRef Kim CH, Vlietstra RE, Edwards WD, Reeder GS, Gleich GJ (1984) Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. Am J Cardiol 53:1472–1473PubMedCrossRef
21.
go back to reference Galiuto L, Enriquez-Sarano M, Reeder GS, Tazelaar HD, Li JT, Miller FA Jr, Gleich GJ (1997) Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc 72:603–610PubMedCrossRef Galiuto L, Enriquez-Sarano M, Reeder GS, Tazelaar HD, Li JT, Miller FA Jr, Gleich GJ (1997) Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc 72:603–610PubMedCrossRef
22.
go back to reference Yanagisawa T, Inomata T, Watanabe I, Maekawa E, Mizutani T, Shinagawa H, Koitabashi T, Takeuchi I, Izumi T (2011) Clinical significance of corticosteroid therapy for eosinophilic myocarditis. Int Heart J 52:110–113PubMedCrossRef Yanagisawa T, Inomata T, Watanabe I, Maekawa E, Mizutani T, Shinagawa H, Koitabashi T, Takeuchi I, Izumi T (2011) Clinical significance of corticosteroid therapy for eosinophilic myocarditis. Int Heart J 52:110–113PubMedCrossRef
23.
go back to reference Kawano S, Kato J, Kawano N, Yoshimura Y, Masuyama H, Fukunaga T, Sato Y, Maruyama H, Mihara K, Ueda A, Toyoda K, Imamura T, Kitamura K (2011) Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med 50:975–981PubMedCrossRef Kawano S, Kato J, Kawano N, Yoshimura Y, Masuyama H, Fukunaga T, Sato Y, Maruyama H, Mihara K, Ueda A, Toyoda K, Imamura T, Kitamura K (2011) Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med 50:975–981PubMedCrossRef
24.
go back to reference Corradi D, Vaglio A, Maestri R, Legname V, Leonardi G, Bartoloni G, Buzio C (2004) Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 35:1160–1163PubMedCrossRef Corradi D, Vaglio A, Maestri R, Legname V, Leonardi G, Bartoloni G, Buzio C (2004) Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 35:1160–1163PubMedCrossRef
25.
go back to reference Wojciechowska C, Gala A, Kuczaj A, Jachec W, Foremny A, Helbig G, Wojnicz R, Nowalany-Kozielska E (2011) Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome. Int Heart J 52:194–196PubMedCrossRef Wojciechowska C, Gala A, Kuczaj A, Jachec W, Foremny A, Helbig G, Wojnicz R, Nowalany-Kozielska E (2011) Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome. Int Heart J 52:194–196PubMedCrossRef
Metadata
Title
Response to Corticosteroids and Cytotoxic Drugs in a Case of Idiopathic Hypereosinophilic Syndrome with Predominantly Elevated Eosinophils and Multiple Clinical Manifestations
Authors
Zhi-ping Guo
Lin-hua Yang
Jian-fang Chen
Xiu-hua Chen
Yao-fang Zhang
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-013-0310-z

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine